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Distinct stages during colonization of
the mouse gastrointestinal tract by
Candida albicans
Daniel Prieto and Jesús Pla *
Departamento de Microbiología II, Facultad de Farmacia, Universidad Complutense de Madrid, Madrid, Spain
Candida albicans is a member of the human microbiota, colonizing both the vaginal
and gastrointestinal tracts. This yeast is devoid of a life style outside the human body
and the mechanisms underlying the adaptation to the commensal status remain to be
determined. Using a model of mouse gastrointestinal colonization, we show here that
C. albicans stably colonizes the mouse gut in about 3 days starting from a dose as low
as 100 cells, reaching steady levels of around 107 cells/g of stools. Using fluorescently
labeled strains, we have assessed the competition between isogenic populations from
different sources in cohoused animals. We show that long term (15 days) colonizing cells
have increased fitness in the gut niche over those grown in vitro or residing in the gut
for 1–3 days. Therefore, two distinct states, proliferation and adaptation, seem to exist
in the adaptation of this fungus to the mouse gut, a result with potential significance in
the prophylaxis and treatment of Candida infections.
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Introduction
Fungal agents are an important cause of nosocomial infections, which are a primary health
problem in several countries (Pfaller and Diekema, 2007; Alangaden, 2011). Their treatment,
especially of systemic nosocomial infections is complicated by the limited number of antifungals
available (Ostrosky-Zeichner et al., 2003) and the emergence of resistance to some of the most
commonly used (Cowen et al., 2015). Candida albicans is the most frequent pathogenic fungus
found in humans and the 4th most common cause of blood borne systemic nosocomial infections.
This yeast is found as a harmless commensal in the human population, residing mainly in the
gastrointestinal and vaginal tract. Under impairment of physical host barriers and/or alteration
of immune defenses (Romani, 2004), C. albicans is able to translocate through the mucosa and
gain access to internal organs, causing a systemic disease and organ failure (Mavor et al., 2005).
Genetic evidence supports that C. albicans strains found in the bloodstream are genetically similar
to those found in rectal isolates and that increased gut colonization is, as maybe expected, a risk
for dissemination (Miranda et al., 2009). C. albicans infections are, therefore, mainly endogenous
(Odds et al., 2006). Understanding the mechanisms that control the establishment of this microbe
in host niches is essential for designing strategies to treat and prevent fungal infections (Pierce and
Lopez-Ribot, 2013; Paul and Moye-Rowley, 2014).
The development of genetic tools for this organism (De Backer et al., 2000; Berman and Sudbery,
2002; Hernday et al., 2010; Vyas et al., 2015) has enabled the identification of several virulence
genes, although the concept of virulence itself may be difficult to define for commensal microbes
(Casadevall and Pirofski, 2003). Most virulence genes identified to date encode adhesionmolecules,
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metabolic enzymes, regulators of morphologic changes (such as
the white-opaque) and members of signaling pathways (Mayer
et al., 2013). Of particular interest is dimorphism, which is
triggered in response to certain environmental factors, and
that influences C. albicans ability to invade and proliferate
within tissues and cope with immune cells (Saville et al., 2003,
2006; Gow et al., 2012; Jacobsen et al., 2012). These works
have mainly used the mouse systemic model of infection and,
more recently, alternative non-vertebrate models (Fuchs and
Mylonakis, 2006; Arvanitis et al., 2013) that, unfortunately,
do not mimic the natural route of C. albicans infections
in humans. The development of models of gastrointestinal
commensalism (Koh, 2013) has been a main advantage to
analyze fungal factors influencing colonization. Although initial
studies involved neonatal mice (de Repentigny et al., 1992),
the most common system uses adult mice with a significant
chemotherapy-driven microbiota reduction (Kinneberg et al.,
1999; Mellado et al., 2000; Wiesner et al., 2001). These models
have enabled the definition of the role that neutrophils have in
the control of C. albicans dissemination (Koh et al., 2008) as well
as provided experimental support for the role that certain yeast
may have in the control and outcome of C. albicans colonization
(Jawhara and Poulain, 2007). The development of these models
has enabled to define the role that certain genes have on the
commensal program promoting colonization via yet undefined
regulatory circuits (White et al., 2007; Pierce and Kumamoto,
2012; Pande et al., 2013; P´erez et al., 2013; Prieto et al., 2014).
In this work we have addressed the temporal dependence of
C. albicans adaptation to the mouse gastrointestinal tract. We
have previously developed a dual labeled system that enables
tracing populations in the gut via flow cytometry or standard
viable colony counting (Prieto et al., 2014). Using this system
and measuring competitive fitness between different fungal
populations, we were able to show how C. albicans cells adapt to
the commensal status in a timely fashion.
Materials and Methods
Strains and Growth Conditions
C. albicans strains used in this work were CAF2-GFP (COA6-
3) and CAF2-dTOM2 (PPD7), both described in a previous
work (Prieto et al., 2014). The only genetic difference between
the two strains is the fluorescence label (GFP or RFP), which
does not impose any loss of fitness to the population allowing
the differentiation of each strain from a mixed population in
colonies (Prieto et al., 2014). According to our nomenclature
(Table 1), Ca-n refers to C. albicans cells grown in vitro (YPD),
TABLE 1 | Nomenclature of C. albicans populations studied in this work.
Nomenclature Origin State Description
Ca-n C. albicans cells obtained under standard laboratory conditions In vitro Stationary overnight cells
Ca-g C. albicans cells present in the gut In vivo Short term (2 days, Ca-gS) or Long term (>14 days, Ca-gL) after gavage
Ca-f C. albicans cells derived from animal feces Ex vivo Ca-fS (Short term, 2 days) or Ca-fL (Long term, 21 days) refers to original
state of the animal in the moment of cohousing
Ca-g refers to cells present in the gut and Ca-f to cells derived
from stools (in a cohousing experiment). In some experiments,
the genetic label of the cells (GFP, RFP) was swapped among
the different physiological status (n, g, or f) to discard any
role of the fluorescent label in terms of fitness. In these cases,
all data have been plotted together as they were practically
identical.
Ca-n population was obtained from an overnight (24 h)
culture at 37◦C in YPD liquid medium (2% glucose, 2% peptone,
1% yeast extract) of CAF2-GFP (COA6-3) or CAF2-dTOM2
(PPD7). These strains were obtained starting from fresh YPD
plates derived from a −80◦C glycerol stock and kept at 4◦C
for 2–4 weeks. Overnight cells were recovered by a low speed
centrifugation (3000 r.p.m for 5min) and resuspended in PBS.
Different number of cells (see description of each experiment) in
a volume of 100µL were inoculated by gavage. Stools samples
were plated in SD solid medium (2% glucose, 0.5% ammonium
sulfate, 0.17% yeast nitrogen base and 2% agar) plus amino acids
and chloramphenicol (10µg/mL) for colony counting.
In vivo Procedures
The experiments involving animals performed in this work
were carried out in strict accordance with the regulations
in the “Real Decreto 1201/2005, BOE 252” for the Care
and Use of Laboratory Animals of the “Ministerio de la
Presidencia,” Spain. The protocol was approved by the Animal
Experimentation Committee of the University Complutense
of Madrid (Permit Number: CEA 25/2012, BIO2012-31839-1).
All efforts were made to minimize suffering. Mice euthanasia
was performed by CO2 inhalation following standard protocols
(AVMAGuidelines for the Euthanasia of Animals: 2013 Edition).
The number of animals used was minimized for ethical
reasons.
Female mice C57BL/6 obtained from Harlan Laboratories
Inc. (Italy) were used within an age of 7–10 weeks-old. Mice
housing and other non-invasive procedures took place in the
animal facility from the Medical School of the Universidad
Complutense de Madrid. We used the protocol for studying
commensal colonization that we have previously described
(Prieto et al., 2014) with minor modifications. After 4 days
of antibiotic pretreatment (2 mg/mL Streptomycin, 1 mg/mL
Bacitracin, and 0.1 mg/mL Gentamicin) in drinking water, C.
albicans cells were inoculated in a single gavage with a specific
dose. In some experiments, a second inoculation was performed
on days 2, 15, or 21 to establish a competition among different
populations and in vitro cells. In the cohousing experiments,
mice were maintained in the same cage without any artificial
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inoculation. For all the experiments, colonization was assessed
by measuring CFUs (Colony Forming Units) of C. albicans in
freshly obtained stools. Fresh stool samples were collected from
each individual on different days, mechanically homogenized
in PBS to 40 mg/mL and viable cells were determined on SD-
agar plates. Colonies were associated to a specific population in
accordance to the colony color (red colonies, RFP expressing
cells; white-greenish colonies, GFP expressing cells). Proportions
of populations lower than ∼1:10,000 could not be distinguished
on plates. The detection limit of our technique in competition
experiments is ∼2500 cells/g stools, which is plotted in some
figures. When fungal levels were below this limit, colonization
was considered 0 for graphical representation. To normalize
fungal levels with the levels at the intervention we used
competition index (CI). For a population A vs. a population
B, CI was calculated in the following way: CIA/BDayX =
(CFUCa−A/CFUCa−B)DayX/(CFU
Ca−A/CFUCa−B)Day1. The value
of 2500 CFU/g stools was used for groups with colonization levels
below detection limit to enable CI calculation.
Statistical Analysis
All statistics have been calculated using GraphPad Prism 5
software. Linear regression was used to compare the decay of
colonization of fungal populations tested after antibiotic removal
on different days. To determine statistical differences among log2
CI values from different experiments and days, we performed
One-Way ANOVA plus Bonferroni’s multiple comparison tests
to compare more than two groups and Student’s two-tailed
unpaired t-tests when there were just two groups. Data shown
in figures are either each replicate and/or mean± standard error.
Results
Equilibrium Levels of C. albicans in Gut
Colonization are Independent of Fungal Dose
Treatment of mice with oral antibiotics has been a broadly
used strategy to allow high C. albicans colonization levels after
gastrointestinal inoculation (Wiesner et al., 2001; Koh, 2013). In
FIGURE 1 | Influence of the inoculum dose in the colonization
levels. After four days of antibiotic treatment, different doses of C.
albicans were orally given. (A) Fungal loads in stools (log CFU per
gram, mean ± SEM) from each group (n = 2) on days 1 and 3. (B)
Relation between levels detected in stools and dose on days 1 and 3
(mean ± SEM).
these protocols, a high dose of C. albicans is normally given either
by a single gavage or via drinking water ad libitum. Oral doses
(about 107 CFUs) are in the range of the levels later obtained from
stools (106–107 CFUs/g stool). It is normally accepted that a high
inoculum may help gut establishment of C. albicans. We tested
this assumption by inoculating 5 groups of mice (n = 2) with
100µL of serial dilutions of a 107 CFUs/mL solution of stationary
C. albicans phase cells. Mice therefore received 106, 105, 104, 103,
or 102 C. albicans cells in a single dose and stool fungal levels were
determined in the following days. At day 1, CFUs obtained from
stools correlated well with the inoculated dose and were roughly
10x higher (in CFUs/g) than the dose. At day 3, they all reached
similar high colonization levels (7.3± 0.23, mean of Log (CFU/g)
± SEM), independently of the dose received (Figure 1). Ratios
between stool concentration values at day 1 and dose inoculum
was found to be very similar for all groups, 1.3 ± 0.15 [Log
(CFU/g)/Log (CFU inoculated), mean ± SEM], suggesting that
cells proliferated rather similarly during this period. This result
indicates that the first 72 h after inoculation are critical for C.
albicans to proliferate and attain stable stationary colonization
levels which are then properly maintained in the next days. We
hypothesized that during this period cells focus on proliferation,
while at later stages,C. albicansmay rely on adaptation to the new
environment.
C. albicans colonization Time Affects Fall of
Fungal Levels after Antibiotics Removal
It is known that modification of the bacterial microbiota is
needed to allow a stable colonization of C. albicans (Koh
et al., 2008). Our colonization protocol is based on application
of a specific antibiotic regime to the mice via the drinking
water (Wiesner et al., 2001) and when removed, fungal loads
decrease (Prieto et al., 2014) allowing efficient removal of C.
albicans from the mouse gut. We wondered if this decline would
occur similarly to gut-adapted or non-adapted populations of C.
albicans. We used for this purpose cells obtained from in vitro
standard laboratory growth conditions (that we call Ca-n, for
non-adapted), and cells already present in the mouse gut (Ca-g,
for gut adapted). We also distinguished between short-term
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adapted (Ca-gS) cells for those present in the gut for 2 days and
long-term adapted (Ca-gL) when they have established in the gut
for 2 or more weeks (see Table 1 and Materials and Methods).
We therefore treated 3 groups of mice with antibiotics for 4
days and afterwards 107 C. albicans cells were inoculated to each
individual. Antibiotic therapy was removed from experimental
groups at different time points: group 1 mice lacked antibiotics in
drinking water immediately after inoculation (day 0), in group 2,
antibiotic therapy was removed 2 days after inoculation (Ca-gS)
while in group 3 cells were allowed to colonize for 23 days (Ca-
gL). After oral antibiotics were removed, fungal loads on stools
were analyzed at different days (0, 1, 8, 13, and 21). To assess the
colonization decrease rate and be able to compare the behavior of
different groups, we calculated linear regression of fungal loads
(log CFU/g) at different time points (Figure 2A). Ca-gL group
showed the lowest fall of colonization (0.117 log units per day),
while groups Ca-gS and Ca-n displayed slopes of 0.263 and 0.209,
respectively, roughly inversely correlating with colonization time.
Actually, only Ca-gL group linear regression differed significantly
from the other two groups (p < 0.01 for Ca-n and p < 0.001
for Ca-gS). Ca-gS and Ca-n did not show a significant different
behavior. Since each group presents a different colonization level
after antibiotic removal, we calculated ratios of fungal loads
referring to the value attained at day 0 (Figure 2B). At day 1,
all groups present similar log2 values close to 0, indicating that
no important changes had affected the C. albicans populations
yet. All groups experienced an important drop in fungal loads
in the following days. This effect was less pronounced in Ca-gL
group and, interestingly, much more in Ca-gS population. The
latter was significantly different from the other two groups, on
both days 8 and 13. However, on day 21 no significant differences
among groups were observed.
Long-term (But Not Short-term) Gut-adapted C.
albicans Cells Displace Non-adapted Fungal
Populations
In order to determine the fitness of different adapted C. albicans
cells, we used our recently developed red or green fluorescent
gene reporter system (Prieto et al., 2014) to distinguish between
these populations. We used cells labeled with either GFP or
RFP which were allowed to colonize mice thus generating
Ca-gS and Ca-gL populations. Mice were inoculated by gavage
with C. albicans cells (normally GFP-labeled) and after 2 or
15–21 days, a new Ca-n population was introduced (then
RFP-labeled) to allow competition with already established Ca-
gS and Ca-gL (respectively) present populations. At different
times, the abundance of each population was determined in
stool samples from every mouse (Figure 3). Different doses
of Ca-n were tested to ensure that competition would not
be critically dependent on the load (dose) of C. albicans
inoculated.
We noticed that a Ca-n population easily maintains sustained
levels of colonization in the gut when it competes with Ca-gS
(Figures 3A,C,E). Although lower levels of Ca-n are detected in
stools when inoculating low doses (Figures 3A,C), the pattern
from the first day is rather constant. However, in the presence
of a Ca-gL population, Ca-n is unable to establish and attain high
FIGURE 2 | Decay of colonization of different C. albicans populations
after antibiotic removal. Antibiotic treatment was replaced with sterile water
in each group (n = 4) on day 0 (Ca-n, open circles), day 2 (Ca-gS, gray
squares) or day 23 (Ca-gL, black triangles) from the inoculation of 107 cells of
C. albicans. Each symbol represents data from an individual mouse. (A)
Evolution of fungal loads in stools (log CFU per gram) along 21 days after the
antibiotic treatment was removed. (B) Ratios of fungal levels (CFU per gram) in
relation to the day when antibiotics was removed (day 0). *p < 0.05,
**p < 0.01, ***p < 0.001.
colonization loads (Figures 3B,D,F). Only upon inoculation of a
high dose (107 cells) of Ca-n cells, these cells were eventually able
to establish in the gut. Notably, the colonization levels attained
by Ca-n are lower to those found at day 1, which probably
reflect transient passage through the gastrointestinal tract but not
equilibrium levels (Figure 3F).
Since each strain is inoculated on different days (days 2, 15,
or 21), it is difficult to compare the evolution of the populations
in competitive fitness. We chose to use the proportions of
strains determined in stool samples at day 1 as this value nicely
correlates with the proportion in the mix inoculated in standard
colonization competition assays in mice (Figure S1). We used
colonization competition index (CI) (seeMaterials andMethods)
as it actually reflects the ability of one population to persist
over the other one. Using this parameter, we have analyzed
whether the dose and/or stage of previous population influence
the subsequent competition. While a high C. albicans dose (107
cells) helps Ca-n to reach higher fungal levels on day 1, it
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FIGURE 3 | Competition in colonization among Ca-n and Ca-g C.
albicans populations. Competition between Ca-n and Ca-g
populations was performed through inoculation of cells from in vitro
culture in the day and doses indicated. Colonies were associated to a
specific population in accordance to the fluorescent label. A value of 0
is attributed to non-detected-populations. Stool levels (log CFU per
gram, mean ± SEM) are represented along the time. (A) Ca-gS vs. 106
cells of Ca-n (n = 3); (B) Ca-gL vs. 106 cells of Ca-n (n = 7); (C)
Ca-gS vs. 5× 106 cells of Ca-n (n = 5); (D) Ca-gL vs. 5× 106 cells of
Ca-n (n = 5); (E) Ca-gS vs. 107 cells of Ca-n (n = 6); and (F) Ca-gL
vs. 107 cells of Ca-n (n = 4). DL refers to detection limit as explained
in Materials and Methods section.
does not really impact the outcome of the evolution of the
population levels as no statistically significant differences were
detected in the CIg/n ratio at any dose administered, neither in
short-term or long-term populations (Figures 4A,B). However,
strikingly clear differences appear when comparing Ca-gS and
Ca-gL groups, regardless the dose: the CIg/n was always higher for
C. albicans cells that were in the gut for a long time, that is Ca-gL
outcompetes more efficiently the new Ca-n population than Ca-
gS (Figure 4C). Moreover, we only find values for CIg/n below
1 (negative as a logarithm) in the Ca-gS group. Remarkably,
the mean of this index does not significantly changes within
a group of mice over time (Figure 4C) with log2 values of
1.41 ± 0.36 (day 4), 2.31 ± 0.64 (day 8), 2.41 ± 0.64 (day
13), and 1.17 ± 0.45 (day 15) for short-term group; and 5.38
± 0.69 (day 4), 4.54 ± 0.64 (day 8), 6.34 ± 0.49 (day 13),
and 6.79 ± 0.73 (day 15) for Ca-gL group (log2CI
g/n, mean ±
SEM).
Collectively, these results demonstrate that Ca-gL cells show
increased fitness over Ca-gS in competition experiments with a
freshly inoculated C. albicans cell population, therefore reflecting
different adaptation to the host.
Gut-adapted C. albicans cells are Efficiently
Maintained during Cohousing Experiments
In order to determine more precisely the behavior of gut-
adapted populations, we performed competition experiments
between different gut adapted C. albicans populations. For this
purpose, we considered another type of adapted population, Ca-
f (from feces-derived C. albicans, Table 1). We first determined
the ability of antibiotic-treated mice to become colonized from
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FIGURE 4 | Dose and time influence in the colonization fitness.
Differences in fitness are determined through comparison of CI values (log2).
Each symbol represents data from an individual mouse. (A) Effect of dose
among Ca-gS groups (n = 3–6). (B) Effect of dose among Ca-gL groups
(n = 4–7). (C) Effect of the time past in the gut regardless the dose
(n = 14–16). *p < 0.05, ***p < 0.001.
stool samples; this possibility has been recently shown to occur
and provide experimental evidence for horizontal transmission
under specific experimental conditions (Cutler et al., 2011). We
cohoused (same cage) two control mice (i.e., non-inoculated
with C. albicans, only receiving PBS) with 8 mice inoculated
with C. albicans (Figure S2). PBS-mice reached high fungal loads
in stools as early as one day after the cohabitation (mean =
5.79, logCFU/g), although still not reaching the levels of C.
albicans-mice (mean = 7, logCFU/g). At day 2, comparable
fungal loads were found in both groups, PBS or C. albicans-
inoculated (mean = 7.12 and 7.28, respectively). We therefore
conclude that cohousing mice is an efficient and natural way to
spread outC. albicans gut-adapted populations inmice under our
conditions.
We then studied the behavior of short (Ca-fS) and long term
(Ca-fL) Ca-f populations in competition with different Ca-g
populations. For this purpose, 3 groups of mice were allowed
to cohabit (same cage) together: Group 1 had no fungi and
just received antibiotic treatment; Group 2 had colonizing C.
albicans CAF2-dTOM2 on day 2 after gavage (Ca-gS) while
Group 3 had C. albicans CAF2-GFP on day 21 (Ca-gL) after
gavage (see Figure S3). The appearance of C. albicans cells
from different origins was followed in the stools of the animal
in the next 3 weeks. Given the above results, the source of
exogenous (non-gavage mediated) colonization is presumed to
be the stool population (either Ca-fS or Ca-fL). As shown in
Figure 5, all mice presented both GFP and dTOM2-labeled
strains in their stools. This result indicates that Ca-fS and Ca-
fL are efficient to become established within mouse gut even in
the presence of a Ca-g population. However, each population
showed a different evolution. In group 1, as animals were
devoid of fungi, competition is initially established between Ca-
fS and Ca-fL. Both GFP and dTOM2 labeled cells were able
to maintain constant levels (≈105 yeasts per gram, Figure 5A),
indicating that a C. albicans-free gut niche is not restrictive
enough to discriminate between those two populations. Identical
levels achieved by each strain in the first day indicate that
both populations were similarly accessible to mice. In group 2
mice, we also found ≈105 CFUs/g stools of Ca-fL, while the
previous endogenous population (Ca-gS) showed colonization
over 106 CFUs/g. For group 3, steady state levels for Ca-fS and
Ca-gL populations were around 106 and 107 yeasts per gram,
respectively. Interestingly, Ca-fS population peaked at day 1
showing values very similar to endogenous population (mean =
6.7 vs. 6.5, logCFU/g) and later showing a slight decrease. Group
2 involves competition between Ca-gS and Ca-fL (Figure 5B).
The latter did not achieve really high colonization levels at
day 1 (Figure 5B). However, it is evident that it is favored
in competition since mean log2 CI
g/f values were negative
(Figure 6A), that is −0.99 ± 1.61 (day 4), −2.84 ± 0.80 (day
8), −1.95± 1.36 (day 13) and −3.42 ± 1.89 (day 15) (mean
± SEM). In group 3, Ca-fS is more efficient in immediate
survival as it reached the highest loads at day 1, nevertheless
it doesn’t maintain this level during the rest of the experiment
(Figure 5C). In contrast with the previous group, log2 CI
g/f
values were all positive with means around 4–5, confirming that
Ca-fS population fails to outcompete Ca-gL. Taken together, this
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FIGURE 5 | Competition in colonization among Ca-g and Ca-f C.
albicans populations. Competition between Ca-g and Ca-f populations was
performed through putting together mice non-colonized (group 1) and mice
already colonized for 2 or 23 days (groups 2 and 3, respectively). Colonies
were associated to a specific population in accordance to the fluorescent label.
Each symbol represents data from an individual mouse. Stool levels (log CFU
per gram) are represented along the time. (A) Group 1: Ca-fS vs. Ca-fL (n = 3);
(B) Group 2: Ca-gS vs. Ca-fL (n = 3); (C) Group 3: Ca-gL vs. Ca-fS (n = 3).
reveals that the population Ca-fL suffers a slight impairment
in the early colonization stage (establishment and immediate
survival) for which Ca-fS population is better adapted.
Regarding the second stage, Ca-fL population is conveniently
prepared for persisting in the gut, while Ca-fS shows some
difficulties competing with a population adapted to this stage
(Figures 5B,C). In addition, calculated CIL/S show a similar
competition between long-term and short-term, independently
of the adapted-C. albicans source (Figure 6B). Although Group 3
presented always higher CIL/S means than group 2 (especially on
day 4), the differences are not significant (for day 4, p = 0.131).
However, we observe a reduction in fitness in short-term adapted
populations (from either gut or feces) at all times compared with
Ca-fL or Ca-gL, confirming an important difference between
those populations and an advantage for long-term adaptation in
persisting in the gut (Figure 6A).
Discussion
Adaptation to host environment is a necessary trait for any
commensal microbe. C. albicans is a member of the human
microbiota and during the past few years, several efforts
have been directed toward the identification of mechanisms
responsible for its relationship with humans. The development of
commensalism models, normally based on antibiotic-mediated
microbiota reduction, is enabling the exploration of this essential
aspect of the host-fungus interaction. Initial studies by Kinneberg
et al. (1999), showed that inoculation with 103 or 107 C. albicans
cells resulted in high colonization of the cecum after 3 or 7
days, but no information was provided for earlier time points.
We show here that as early as 3 days after inoculation, steady
levels of 107 CFUs per gram in stools are usually attained
starting from as low as 100 cells inoculated. Given the correlation
between oral doses and stool levels and the increase in up to 5
logarithmic units, it seems that during this period C. albicans
cells focus on proliferation. Since after 3 days we already observe
steady colonization levels (∼107 CFU/g) we chose 2 days of
colonization as representative of this period for comparative
studies. We show here that populations that had colonized
the intestine for a long time (15–21 days) (Ca-gL) display
enhanced fitness over those that had been in the gut for few
(2) days (Ca-gS) or in vitro cells (Ca-n). This is evidenced
by their reduced kinetics of disappearance from the gut after
removal of antibiotic therapy and by the increased competition
in vitro cells compared with Ca-gS. In fact, a conclusion from
our studies is that colonization levels do not correlate with
fitness as Ca-n rapidly aquire high colonization levels but do
still show decreased fitness. Therefore, we propose that initial
stages of colonization in our experimental system are mainly
responsible for attaining high fungal doses (replication period)
but full adaptation (at least, in terms of competitiveness) is
only achieved after a more prolonged time (adaptation). Similar
behaviors are also observed when the adapted populations came
from feces (through coprophagy). Using transcriptomal analysis,
several genes have been shown to be differentially expressed in
the gut (Rosenbach et al., 2010). Many of these genes were also
expressed either during growth in exponential phase or post-
exponential-phase, suggesting correlation with both its ability
to grow quickly (characteristic of exponential phase) and the
resistance to different types of stress (more prone to stationary
phase) in accordance with the challenging environment (nutrient
competition, pH, oxygen availability and microbial interactions)
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FIGURE 6 | Dose and time influence in the colonization fitness. Differences in fitness are determined through comparison of CI values (log2). (A) Effect of the
time past in the gut. (B) Effect of the source. *p < 0.05.
that cells encounter in this niche. Such a scenario is in accordance
with recent data that indicate that identified transcription
regulators of commensalism mainly affect functions involved in
carbon and nitrogen metabolism (P´erez et al., 2013). In any case,
in Rosenbach’s study cells were harvested from cecum just 3
days after inoculation, so we would associate it with our Ca-gS
population.
The existence of different stages in fungal colonization would,
in addition, explain some observations from literature. For
example, while MAPK signaling pathways are important in
mouse gut colonization (Prieto et al., 2014), defects in Hog1
results in an immediate impairment to colonize mouse gut
(especially when a competition assay with a wild type strain is
performed), although others such as Mkc1 and Cek1 changes
result in long terms defects. Moreover, it has been reported that
efh1 and efg1mutant cells develop higher gut establishment levels
than the wild type strain and it is considered as colonization
specific transcription factor (White et al., 2007; Pande et al., 2013;
Pierce et al., 2013). This phenotype resembles what we observe
in in the Ca-gS population, suggesting that these factors (and
possibly Wor1) could play a role in this initial adaptation.
The existence of different stages for colonizing the gut has
been proposed also for other microorganisms. For example, in
Vibrio cholerae (Lee et al., 1999; Schild et al., 2007) an early
period is essential for survival and multiplication in vivo, while
prolonged period allows bacteria to live outside the host, where
nutrients amounts are much lower. Host-induced shedding
seems to be also a strategy used by the microbe for dissemination
(Merrell et al., 2002; Almagro-Moreno et al., 2015). AsC. albicans
is a long-term permanent colonizer of the gut tract with no
significant life outside the host (“after-hours”), our observations
could reflect adaptation to host from domesticated laboratory
strains. It has been reported that another gut-colonizer,
Salmonella typhimurium, would derivate into two phenotypically
different populations, one becoming pathogenic to improve the
chances of the second one to colonize and outcompete the
microbiota present in the gut (Stecher et al., 2007). In addition,
different C. albicans levels in the gut have been proposed to be
associated with the existence of hypothetical phenotypic variants
(similarly than those from S. typhimurium) that appear during
host colonization (Kumamoto, 2011). Such a scenario is in
accordance with high fungal loads of C. albicans in the gut being
a risk factor for developing a systemic infection and frequently
associated with inflammatory bowel disease (Gerard et al., 2015).
This interplay is multifactorial, as commensalism is not only a
microbe-driven process but dependent on the immunological
status of the host (Romani, 2004; Zelante et al., 2012) and even in
immune competent mice, host factors (such as the mucins) can
suppress virulence attributes (Kavanaugh et al., 2014).
In conclusion, we present here evidence that in C. albicans
two different (at least, in terms of fitness) stages exist during
the colonization of mouse gut with laboratory maintained strains
of C. albicans. As this species is a non-habitual member of
the mouse gut microbiota (Iliev et al., 2012), caution must
be taken in interpreting these observations, but determining
whether this occurs in its natural reservoir (humans) is crucial
given its potential implications in the management of C. albicans
infections.
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Figure S1 | Correlation between strains composition in the
inoculum and day 1 stool population. Data from several
competition experiments were collected. Each point correspond to one
experiment that include some mice (n = 3–6). Percentage of RFP
labeled strain in the mixed inoculum and percentage of the same
strain in the stools samples on day 1 were plotted and lineal
regression was performed.
Figure S2 | Fungal loads in mice stools of naturally acquired C. albicans
populations. Eight mice out of ten were inoculated with C. albicans (107 cells)
after four days of antibiotic treatment. The other two mice were inoculated with
PBS and all of them were kept in the same cage. Fungal loads in stools (log CFU
per gram, mean ± SEM) from each group are represented along the time.
Figure S3 | Scheme of cohousing experiment.
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